These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26881708)

  • 41. Amyloid β-targeted metal complexes for potential applications in Alzheimer's disease.
    Liu H; Qu Y; Wang X
    Future Med Chem; 2018 Mar; 10(6):679-701. PubMed ID: 29400551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flavonoid-metal ion complexes: a novel class of therapeutic agents.
    Selvaraj S; Krishnaswamy S; Devashya V; Sethuraman S; Krishnan UM
    Med Res Rev; 2014 Jul; 34(4):677-702. PubMed ID: 24037904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of terminal dimethylation and metal coordination of proline-2-formylpyridine thiosemicarbazone hybrids on lipophilicity, antiproliferative activity, and hR2 RNR inhibition.
    Bacher F; Dömötör O; Kaltenbrunner M; Mojović M; Popović-Bijelić A; Gräslund A; Ozarowski A; Filipovic L; Radulović S; Enyedy ÉA; Arion VB
    Inorg Chem; 2014 Dec; 53(23):12595-609. PubMed ID: 25391085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manganese-induced neurodegenerative diseases and possible therapeutic approaches.
    Martins AC; Gubert P; Villas Boas GR; Meirelles Paes M; Santamaría A; Lee E; Tinkov AA; Bowman AB; Aschner M
    Expert Rev Neurother; 2020 Nov; 20(11):1109-1121. PubMed ID: 32799578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationships of mononuclear metal-thiosemicarbazone complexes endowed with potent antiplasmodial and antiamoebic activities.
    Bahl D; Athar F; Soares MB; de Sá MS; Moreira DR; Srivastava RM; Leite AC; Azam A
    Bioorg Med Chem; 2010 Sep; 18(18):6857-64. PubMed ID: 20719524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metal ion physiopathology in neurodegenerative disorders.
    Bolognin S; Messori L; Zatta P
    Neuromolecular Med; 2009; 11(4):223-38. PubMed ID: 19946766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.
    Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang ML; Lane DJR; Lok H; Richardson DR
    Curr Med Chem; 2019; 26(2):302-322. PubMed ID: 28685681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
    Khanam H; Ali A; Asif M; Shamsuzzaman
    Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growing synergy of nanodiamonds in neurodegenerative interventions.
    Saraf J; Kalia K; Bhattacharya P; Tekade RK
    Drug Discov Today; 2019 Feb; 24(2):584-594. PubMed ID: 30408527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations.
    Jellinger KA
    Int Rev Neurobiol; 2013; 110():1-47. PubMed ID: 24209432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases.
    Pong K; Zaleska MM
    Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):349-56. PubMed ID: 14683462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coordination of thiosemicarbazones and bis(thiosemicarbazones) to bismuth(III) as a strategy for the design of metal-based antibacterial agents.
    Lessa JA; Reis DC; Da Silva JG; Paradizzi LT; da Silva NF; Carvalho Mde F; Siqueira SA; Beraldo H
    Chem Biodivers; 2012 Sep; 9(9):1955-66. PubMed ID: 22976983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipophilic antioxidants in neurodegenerative diseases.
    Chang KH; Cheng ML; Chiang MC; Chen CM
    Clin Chim Acta; 2018 Oct; 485():79-87. PubMed ID: 29940147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiretroviral activity of thiosemicarbazone metal complexes.
    Pelosi G; Bisceglie F; Bignami F; Ronzi P; Schiavone P; Re MC; Casoli C; Pilotti E
    J Med Chem; 2010 Dec; 53(24):8765-9. PubMed ID: 21121632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurodegenerative diseases and oxidative stress.
    Barnham KJ; Masters CL; Bush AI
    Nat Rev Drug Discov; 2004 Mar; 3(3):205-14. PubMed ID: 15031734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
    Lim JK; Mathias CJ; Green MA
    J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide therapeutics in neurodegenerative disorders.
    Tiwari SK; Chaturvedi RK
    Curr Med Chem; 2014; 21(23):2610-31. PubMed ID: 24533803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metals and metal derivatives in medicine.
    Colotti G; Ilari A; Boffi A; Morea V
    Mini Rev Med Chem; 2013 Feb; 13(2):211-21. PubMed ID: 23438056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, structure and antifungal activity of thiophene-2,3-dicarboxaldehyde bis(thiosemicarbazone) and nickel(II), copper(II) and cadmium(II) complexes: unsymmetrical coordination mode of nickel complex.
    Alomar K; Landreau A; Allain M; Bouet G; Larcher G
    J Inorg Biochem; 2013 Sep; 126():76-83. PubMed ID: 23792913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.
    Li Y; Jiao Q; Xu H; Du X; Shi L; Jia F; Jiang H
    Front Mol Neurosci; 2017; 10():339. PubMed ID: 29114205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.